215 related articles for article (PubMed ID: 34279913)
21. Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia.
Roberts J; Desai N; McCoy J; Goren A
Dermatol Ther; 2014; 27(4):252-4. PubMed ID: 24773771
[TBL] [Abstract][Full Text] [Related]
22. Androgenetic Alopecia: An Update of Treatment Options.
Kelly Y; Blanco A; Tosti A
Drugs; 2016 Sep; 76(14):1349-64. PubMed ID: 27554257
[TBL] [Abstract][Full Text] [Related]
23. Dissolving microneedles for alopecia treatment.
Xiang H; Xu S; Zhang W; Xue X; Li Y; Lv Y; Chen J; Miao X
Colloids Surf B Biointerfaces; 2023 Sep; 229():113475. PubMed ID: 37536169
[TBL] [Abstract][Full Text] [Related]
24. Novel enzymatic assay predicts minoxidil response in the treatment of androgenetic alopecia.
Goren A; Castano JA; McCoy J; Bermudez F; Lotti T
Dermatol Ther; 2014; 27(3):171-3. PubMed ID: 24283387
[TBL] [Abstract][Full Text] [Related]
25. Minoxidil Nanosuspension-Loaded Dissolved Microneedles for Hair Regrowth.
Hamed R; Alhadidi HFI
AAPS PharmSciTech; 2024 Apr; 25(4):75. PubMed ID: 38580793
[TBL] [Abstract][Full Text] [Related]
26. Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia.
Guo Y; Qu Q; Chen J; Miao Y; Hu Z
Lasers Med Sci; 2021 Jun; 36(4):703-713. PubMed ID: 33111207
[TBL] [Abstract][Full Text] [Related]
27. Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice.
Liu X; Kong X; Xu L; Su Y; Xu S; Pang X; Wang R; Ma Y; Tian Q; Han L
Int J Pharm; 2024 Apr; 654():123963. PubMed ID: 38430952
[TBL] [Abstract][Full Text] [Related]
28. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility and validity of minoxidil response testing in androgenetic alopecia.
Goren A; Shapiro J; Roberts J; McCoy J; Desai N; Zarrab Z; Pietrzak A; Lotti T
Dermatol Ther; 2015; 28(1):13-6. PubMed ID: 25112173
[TBL] [Abstract][Full Text] [Related]
30. Multi-therapies in androgenetic alopecia: review and clinical experiences.
Rossi A; Anzalone A; Fortuna MC; Caro G; Garelli V; Pranteda G; Carlesimo M
Dermatol Ther; 2016 Nov; 29(6):424-432. PubMed ID: 27424565
[TBL] [Abstract][Full Text] [Related]
31. Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia.
Day D; McCarthy M; Talaber I
J Cosmet Dermatol; 2022 May; 21(5):2056-2063. PubMed ID: 34435735
[TBL] [Abstract][Full Text] [Related]
32. Management of androgenetic alopecia.
Tosti A; Camacho-Martinez F; Dawber R
J Eur Acad Dermatol Venereol; 1999 May; 12(3):205-14. PubMed ID: 10461639
[TBL] [Abstract][Full Text] [Related]
33. Low-Level Light Therapy Downregulates Scalp Inflammatory Biomarkers in Men With Androgenetic Alopecia and Boosts Minoxidil 2% to Bring a Sustainable Hair Regrowth Activity.
Mahe YF; Cheniti A; Tacheau C; Antonelli R; Planard-Luong L; de Bernard S; Buffat L; Barbarat P; Kanoun-Copy L
Lasers Surg Med; 2021 Nov; 53(9):1208-1219. PubMed ID: 33973663
[TBL] [Abstract][Full Text] [Related]
34. Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil
Gentile P; Garcovich S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32295047
[TBL] [Abstract][Full Text] [Related]
35. Vellus-to-terminal Hair Follicle Reconversion Occurs in Male Pattern Balding and is Promoted by Minoxidil and Platelet-rich Plasma: In Vivo Evidence from a New Humanized Mouse Model of Androgenetic Alopecia.
Gilhar A; Keren A; Paus R
Acta Derm Venereol; 2023 Oct; 103():adv12320. PubMed ID: 37853650
[No Abstract] [Full Text] [Related]
36. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
37. Advances in microneedles research based on promoting hair regrowth.
Zhou Y; Jia L; Zhou D; Chen G; Fu Q; Li N
J Control Release; 2023 Jan; 353():965-974. PubMed ID: 36549392
[TBL] [Abstract][Full Text] [Related]
38. Minoxidil: a comprehensive review.
Gupta AK; Talukder M; Venkataraman M; Bamimore MA
J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway.
Bao L; Zong H; Fang S; Zheng L; Li Y
J Dermatolog Treat; 2022 Feb; 33(1):483-493. PubMed ID: 32412314
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
